Back to search

Netherlands· NL-7bd3ed1bac4e

Flumazenil hameln 0,1 mg/ml, oplossing voor injectie/infusie

A flumazenil product containing flumazenil, registered in Netherlands by hameln pharma gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC V03AB25

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFlumazenil hameln 0,1 mg/ml, oplossin…ATCV03AB25REGISTER NO.NL-7bd3ed1bac4ePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Flumazenil is registered in 17 of 19 countries.

Countries holding a registration under ATC V03AB25 (flumazenil), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Flumazenil · ATC V03AB25

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUMAZENIL
Manufacturer
hameln pharma gmbh
Country
Netherlands (NL)
ATC code
V03AB25
ATC class
Flumazenil
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    32035

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for flumazenil.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Flumazenil · interactions on record

63 records

  • 11 severe
  • 16 moderate
  • 3 minor
  • 33 info

Most severe, free to view

  • DoxepinD04AX01severe
  • DesipramineN06AA01severe
  • ImipramineN06AA02severe
  • ClomipramineN06AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flumazenil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flumazenil products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Anexate, Flumazenil B. Braun
  • Belgium · Anexate, Flumazenil B. Braun
  • Czechia · Flumazenil Pharmaselect
  • Germany · Anexate, Flumazenil B. Braun
  • Denmark · Flumazenil Fresenius Kabi, Flumazenil Hameln
  • Spain · Anexate, Flumazenil Altan
  • Finland · Flumazenil B. Braun, Flumazenil Fresenius Kabi
  • France · Flumazenil Hikma, Flumazenil Viatris
  • United Kingdom (Northern Ireland) · Flumazenil Hameln Pharma, Flumazenil Hikma Farmacêutica (Portugal)
  • Greece · Anexate®, Demoxate
  • Croatia · Anexate, Flumazenil B.Braun
  • Hungary · Anexate, Flumazenil Kabi
  • Ireland · Anexate
  • Iceland · Flumazenil B. Braun
  • Italy · Anexate, Flumazenil B. Braun
  • Luxembourg · Flumazenil B. Braun
  • Norway · Flumazenil Fresenius Kabi, Flumazenil Hameln
  • Poland · Flumazenil B. Braun, Flumazenil Kabi
  • Portugal · Flumazenilo Fresenius Kabi, Flumazenilo Generis
  • Romania · Anexate, Flumazenil Pharmaselect
  • Sweden · Flumazenil Fresenius Kabi, Flumazenil Hameln
  • Slovenia · Anexate
  • Slovakia · Flumazenil Pharmaselect

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c54d05fe-9005-4b9b-afea-7460d1ed1d72
GET /v1/drugs/c54d05fe-9005-4b9b-afea-7460d1ed1d72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie, Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h32035_smpc.pdf",
  "strength": null,
  "atc_label": "Flumazenil",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg32035",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "FLUMAZENIL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h32035.pdf",
  "authorised_at": "2005/05/10",
  "procedure_number": "NL/H/0626/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "32035",
  "additional_monitoring": "N"
}

See everything about flumazenil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.